Literature DB >> 13687229

Circulating antibodies in reticuloses.

M BARR, G H FAIRLEY.   

Abstract

Entities:  

Keywords:  ANTIBODIES; RETICULOENDOTHELIOSIS/immunology

Mesh:

Substances:

Year:  1961        PMID: 13687229     DOI: 10.1016/s0140-6736(61)90237-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

2.  Prolonged generalized vaccinia complicating acute leukaemia.

Authors:  E DAVIDSON; F G HAYHOE
Journal:  Br Med J       Date:  1962-11-17

3.  Immune responses in myeloma.

Authors:  A L LINTON; M G DUNNIGAN; J A THOMSON
Journal:  Br Med J       Date:  1963-07-13

4.  Reactivity of red cell eluates and serums in patients with acquired hemolytic anemia and chronic lymphocytic leukemia.

Authors:  J BRODY
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

5.  Hypogammaglobulinaemia in chronic lymphatic leukaemia.

Authors:  G H FAIRLEY; R B SCOTT
Journal:  Br Med J       Date:  1961-10-07

6.  The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions.

Authors:  R van Furth; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1966-07       Impact factor: 7.397

7.  Immunological aspects of reticulum cell neoplasia.

Authors:  A E Stuart
Journal:  Br Med J       Date:  1970-11-14

Review 8.  [Lymphocyte culture and its relation to clinical problems].

Authors:  E Ambs
Journal:  Klin Wochenschr       Date:  1969-08-01

9.  Lymphocyte transformation in diseases of lymphoid tissue.

Authors:  C R Pentycross
Journal:  Proc R Soc Med       Date:  1970-04

10.  The immune response to phichi174 in man. IV. Primary and secondary antibody production in patients with chronic lymphatic leukaemia.

Authors:  T J Hamblin; J V Jones; D B Peacock
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.